226 related articles for article (PubMed ID: 28586250)
1. Pain After Percutaneous Irreversible Electroporation of Renal Tumors Is Not Dependent on Tumor Location.
Sorokin I; Lay AH; Reddy NK; Canvasser NE; Chamarthy M; Cadeddu JA
J Endourol; 2017 Aug; 31(8):751-755. PubMed ID: 28586250
[TBL] [Abstract][Full Text] [Related]
2. Feasibility and safety of irreversible electroporation (IRE) in patients with small renal masses: Results of a prospective study.
Buijs M; Zondervan PJ; de Bruin DM; van Lienden KP; Bex A; van Delden OM
Urol Oncol; 2019 Mar; 37(3):183.e1-183.e8. PubMed ID: 30509869
[TBL] [Abstract][Full Text] [Related]
3. Pain analysis in patients with hepatocellular carcinoma: irreversible electroporation versus radiofrequency ablation-initial observations.
Narayanan G; Froud T; Lo K; Barbery KJ; Perez-Rojas E; Yrizarry J
Cardiovasc Intervent Radiol; 2013 Feb; 36(1):176-82. PubMed ID: 22752100
[TBL] [Abstract][Full Text] [Related]
4. Biliary complications and efficacy after ablation of peribiliary tumors using irreversible electroporation (IRE) or radiofrequency ablation (RFA).
Thamtorawat S; Patanawanitkul R; Rojwatcharapibarn S; Chaiyasoot W; Tongdee T; Yodying J; Sorotpinya S
Int J Hyperthermia; 2022; 39(1):751-757. PubMed ID: 35649727
[TBL] [Abstract][Full Text] [Related]
5. Pain after percutaneous radiofrequency ablation of renal tumors.
Baker M; Anderson JK; Jaffer O; Trimmer C; Cadeddu JA
J Endourol; 2007 Jun; 21(6):606-9. PubMed ID: 17638554
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Chronologic Change in the Size and Contrast-Enhancement of Ablation Zones on CT Images after Irreversible Electroporation and Radiofrequency Ablation.
Scheck J; Bruners P; Schindler D; Kuhl C; Isfort P
Korean J Radiol; 2018; 19(4):560-567. PubMed ID: 29962862
[TBL] [Abstract][Full Text] [Related]
7. Anaesthetic management during open and percutaneous irreversible electroporation.
Nielsen K; Scheffer HJ; Vieveen JM; van Tilborg AA; Meijer S; van Kuijk C; van den Tol MP; Meijerink MR; Bouwman RA
Br J Anaesth; 2014 Dec; 113(6):985-92. PubMed ID: 25173767
[TBL] [Abstract][Full Text] [Related]
8. Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation.
He C; Wang J; Zhang Y; Cai Z; Lin X; Li S
Cancer Med; 2020 Jul; 9(13):4699-4710. PubMed ID: 32410380
[TBL] [Abstract][Full Text] [Related]
9. Minimally Invasive Percutaneous Treatment of Small Renal Tumors with Irreversible Electroporation: A Single-Center Experience.
Trimmer CK; Khosla A; Morgan M; Stephenson SL; Ozayar A; Cadeddu JA
J Vasc Interv Radiol; 2015 Oct; 26(10):1465-71. PubMed ID: 26250855
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors for complete renal tumor ablation using RFA.
Acosta Ruiz V; Lönnemark M; Brekkan E; Dahlman P; Wernroth L; Magnusson A
Acta Radiol; 2016 Jul; 57(7):886-93. PubMed ID: 26452975
[TBL] [Abstract][Full Text] [Related]
11. A retrospective study of CT-guided percutaneous irreversible electroporation (IRE) ablation: clinical efficacy and safety.
Wang Z; Lu J; Huang W; Wu Z; Gong J; Wang Q; Liu Q; Wang C; Zhu Y; Ding X; Wang Z
BMC Cancer; 2021 Feb; 21(1):124. PubMed ID: 33546635
[TBL] [Abstract][Full Text] [Related]
12. Initial Assessment of the Efficacy of Irreversible Electroporation in the Focal Treatment of Localized Renal Cell Carcinoma With Delayed-interval Kidney Tumor Resection (Irreversible Electroporation of Kidney Tumors Before Partial Nephrectomy [IRENE] Trial-An Ablate-and-Resect Pilot Study).
Wendler JJ; Pech M; Fischbach F; Jürgens J; Friebe B; Baumunk D; Porsch M; Blaschke S; Schindele D; Siedentopf S; Ricke J; Schostak M; Köllermann J; Liehr UB
Urology; 2018 Apr; 114():224-232. PubMed ID: 29305201
[TBL] [Abstract][Full Text] [Related]
13. [Ultrasound-guided percutaneous radiofrequency ablation treatment for renal clear cell carcinoma].
Cheng X; Gan W; Xu L; Yao L; Qu F; Zhang G; Li X; Guo H
Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):856-60. PubMed ID: 25604026
[TBL] [Abstract][Full Text] [Related]
14. Tumor Ablation Enhancement by Combining Radiofrequency Ablation and Irreversible Electroporation: An In Vitro 3D Tumor Study.
Zhang B; Yang Y; Ding L; Moser MAJ; Zhang EM; Zhang W
Ann Biomed Eng; 2019 Mar; 47(3):694-705. PubMed ID: 30565007
[TBL] [Abstract][Full Text] [Related]
15. Comparisons of Radiofrequency Ablation, Microwave Ablation, and Irreversible Electroporation by Using Propensity Score Analysis for Early Stage Hepatocellular Carcinoma.
Wada T; Sugimoto K; Sakamaki K; Takahashi H; Kakegawa T; Tomita Y; Abe M; Yoshimasu Y; Takeuchi H; Itoi T
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765689
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Renal Parenchymal Volume Preservation Between Partial Nephrectomy, Cryoablation, and Radiofrequency Ablation Using 3D Volume Measurements.
Woldu SL; Thoreson GR; Okhunov Z; Ghandour R; Rothberg MB; RoyChoudhury A; Kim HH; Bozoghlanian M; Newhouse JH; Helmy MA; Badani KK; Landman J; Cadeddu JA; McKiernan JM
J Endourol; 2015 Aug; 29(8):948-55. PubMed ID: 25578645
[TBL] [Abstract][Full Text] [Related]
17. Comparative Effects of Irreversible Electroporation, Radiofrequency Ablation, and Partial Nephrectomy on Renal Function Preservation in a Porcine Solitary Kidney Model.
Morgan MS; Ozayar A; Lucas E; Friedlander JI; Shakir NA; Cadeddu JA
Urology; 2016 Aug; 94():281-7. PubMed ID: 27155310
[TBL] [Abstract][Full Text] [Related]
18. Similar complication rates for irreversible electroporation and thermal ablation in patients with hepatocellular tumors.
Verloh N; Jensch I; Lürken L; Haimerl M; Dollinger M; Renner P; Wiggermann P; Werner JM; Zeman F; Stroszczynski C; Beyer LP
Radiol Oncol; 2019 Mar; 53(1):116-122. PubMed ID: 30840591
[TBL] [Abstract][Full Text] [Related]
19. Renal tumour nephrometry score does not correlate with the risk of radiofrequency ablation complications.
Seideman CA; Gahan J; Weaver M; Olweny EO; Richter M; Chan D; Cadeddu JA
BJU Int; 2013 Dec; 112(8):1121-4. PubMed ID: 24053576
[TBL] [Abstract][Full Text] [Related]
20. Irreversible Electroporation for the Treatment of Small Renal Masses: 5-Year Outcomes.
Dai JC; Morgan TN; Steinberg RL; Johnson BA; Garbens A; Cadeddu JA
J Endourol; 2021 Nov; 35(11):1586-1592. PubMed ID: 33926224
[No Abstract] [Full Text] [Related]
[Next] [New Search]
